Mantle Cell Lymphoma: ASCO Tumor Boards

This is a case-based activity that includes discussion of a 68-year-old man who presents with palpable cervical lymphadenopathy.  He is a farmer with a past medical history only notable for squamous cell of skin.  Along with the patient case, there is a discussion board on ASCO Connection, where users can post comments/questions to each other and to the faculty.  At the end of this course you should be able to:

  1. Identify clinical and biological prognostic factors in Mantle Cell Lymphoma (MCL).
  2. Discuss the tradeoffs between intensive and non intensive treatment strategies in MCL
  3. Understand the setting in which maintenance rituximab has proven efficacy
  4. Describe the most active novel agent for relapsed MCL
 

This activity was made available on 12/17/2014 and will be reviewed on an annual basis to determine continued availability. A maximum of 1 AMA PRA Category 1 Credit(s) ™ credit is available.

Competencies Addressed

Medical Knowledge (ACGME, AAPA)

Health Promotion, Health Protection, Disease Prevention, and Treatment (ONS)

Note: This course is now accessible through mobile devices as well as personal computers